Skip to content

Selection of individualized analgesic regimen after thyroid or parathyroid surgery: a randomized controlled study

Selection of individualized analgesic regimen after thyroid or parathyroid surgery: a randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075950
Enrollment
Unknown
Registered
2023-09-20
Start date
2023-09-25
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain after surgery

Interventions

Test team:According to the preoperative evaluation of postoperative nausea and vomiting risk factors, depression status and pain sensitivity score, an individualized postoperative analgesia plan was f
Control group:All patients were routinely given sufentanil 1ug/kg+ ondansetron 12mg with a pump of 100ml, and the analgesia pump was connected to the anesthesia resuscitation room by researchers in gr

Sponsors

Department of Anesthesiology, Qilu Hospital of Shandong University Dezhou Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: • Informed consent of patients or their families; • Age 18-70 years old; • ASA classification is I-III; • Patients undergoing thyroidectomy.

Exclusion criteria

Exclusion criteria: • People with chronic pain or taking opioids for a long time; • Emergency operators; • People with cognitive impairment; • History of hypersensitivity (reactions include systemic rash, urticaria and vascular edema); • Patients with a history of gastrointestinal bleeding or perforation after using NSAIDs; • Patients with active digestive tract ulcer/bleeding or recurrent ulcer/bleeding in the past; • Patients with severe heart failure and hypertension; • Patients with severe liver, kidney and blood system dysfunction; • Patients who are using enoxacin, lomefloxacin and norfloxacin. • Combined with major systemic diseases; • Pregnant and lactating women; • Those who can't understand or answer the questionnaire.

Design outcomes

Primary

MeasureTime frame
The Numeric Pain Rating Scale;

Secondary

MeasureTime frame
Dosage of opioid drugs;Postoperative pain score;Nausea Visual Analog Scale Score, Number and Time of Postoperative Vomiting Attacks;Medication costs;Adverse reactions to drug use;Patient's postoperative hospital stay;Time to stop using analgesics and dosage of analgesics;Quality of life score for the first week after surgery;Surgical complications and unplanned diagnosis and treatment within 30 days;

Countries

China

Contacts

Public ContactJianbo Wu

Qilu Hospital of Shandong University Dezhou Hospital

jianbowu@126.com+86 185 6008 3793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026